ONL Therapeutics
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to helping patients see the future.
5
Funding Rounds
$164.3m
Money raised
Funding
Funding series
Funding Series Analysis
The company ONL Therapeutics has raised a total of $111.9m in funding over 5 rounds.
Key Insights:
- ONL Therapeutics September 2024 Series D Funding Round: $65m
- ONL Therapeutics Series B round, January 2022: $46.9m
- ONL Therapeutics, Inc. funding round, August 2019: $3m
- ONL Therapeutics, Inc. funding round, October 2020: $2m
- ONL Therapeutics, Inc. funding round, December 2020: $47.36m
ONL Therapeutics September 2024 Series D Funding Round
$65m
ONL Therapeutics Series B round, January 2022
$46.9m
ONL Therapeutics, Inc. funding round, August 2019
$3m
ONL Therapeutics, Inc. funding round, October 2020
$2m
ONL Therapeutics, Inc. funding round, December 2020
$47.36m
Industries
ONL Therapeutics is active in the following industries: